tiprankstipranks
Trending News
More News >
Santhera Pharmaceuticals Holding (CH:SANN)
:SANN
Switzerland Market

Santhera Pharmaceuticals Holding (SANN) Income Statement

Compare
3 Followers

Santhera Pharmaceuticals Holding Income Statement

Last quarter (Q2 2025), Santhera Pharmaceuticals Holding's total revenue was CHF24.01M, an increase of 509.62% from the same quarter last year. In Q2, Santhera Pharmaceuticals Holding's net income was CHF-38.83M. See Santhera Pharmaceuticals Holding’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
CHF 39.12MCHF 103.41MCHF 7.47MCHF -1.59MCHF 15.01M
Gross Profit
CHF 22.96MCHF 100.18MCHF 3.88MCHF -5.36MCHF 4.58M
Operating Expenses
CHF 56.69MCHF 31.34MCHF 55.86MCHF 51.53MCHF 57.65M
Depreciation and Amortization
CHF 5.65MCHF 3.04MCHF 3.65MCHF 3.72MCHF 7.14M
EBITDA
CHF -15.89MCHF 79.17MCHF -46.78MCHF -34.57MCHF -53.43M
Operating Income
CHF -33.38MCHF 68.84MCHF -51.98MCHF -56.89MCHF -53.08M
Other Income/Expenses
CHF -8.28MCHF -14.02MCHF -18.64MCHF 2.17MCHF -14.38M
Pretax Income
CHF -41.66MCHF 54.82MCHF -70.62MCHF -54.72MCHF -67.46M
Net Income
CHF -41.97MCHF 54.78MCHF -71.08MCHF -55.53MCHF -67.66M
Per Share Metrics
Basic EPS
CHF -3.69CHF 5.18CHF -11.67CHF -16.25CHF -50.81
Diluted EPS
CHF -3.69CHF 5.01CHF -11.67CHF -16.25CHF -50.81
Weighted Average Shares Outstanding
11.38M 10.58M 6.09M 3.42M 1.33M
Weighted Average Shares Outstanding (Diluted)
11.38M 10.92M 6.09M 3.42M 1.33M
Currency in CHF

Santhera Pharmaceuticals Holding Earnings and Revenue History